XIRP2 antibodies are immunological reagents specifically designed for the detection and study of xin actin binding repeat containing 2 (XIRP2), a large structural protein with crucial functions in actin cytoskeleton maintenance. These antibodies have become indispensable tools in molecular biology and biomedical research, enabling the visualization and characterization of XIRP2 protein in various cellular contexts. XIRP2 antibodies are available in different formats, including unconjugated, HRP-conjugated, and biotin-labeled versions, providing researchers with flexibility in experimental design based on specific research needs .
XIRP2 antibodies are available in both polyclonal and monoclonal formats, each offering distinct advantages for different applications. Polyclonal antibodies, such as the rabbit polyclonal antibody produced by Proteintech (catalog number 11896-1-AP), recognize multiple epitopes on the XIRP2 protein, enhancing detection sensitivity . These antibodies are typically generated through immunization of host animals with XIRP2 fusion proteins or specific peptide sequences derived from the target protein.
The host species for commercially available XIRP2 antibodies include rabbit and mouse, with rabbit being the most common. For instance, Abbexa offers a rabbit polyclonal XIRP2 antibody conjugated with HRP, specifically targeting human XIRP2 . The immunogen for this particular antibody is a recombinant human XIRP2 protein fragment spanning amino acids 2861-3004 .
Most commercial XIRP2 antibodies are supplied in liquid form with specific storage buffers designed to maintain stability and activity. For example, the Proteintech XIRP2 antibody (11896-1-AP) is provided in PBS with 0.02% sodium azide and 50% glycerol at pH 7.3 . This formulation enables long-term storage at -20°C with maintained activity for at least one year after shipment.
The purity of XIRP2 antibodies is typically high, with products like the Abbexa XIRP2 antibody-HRP reporting a purity greater than 95% after protein G purification . This high purity is essential for reducing background and non-specific binding in sensitive applications.
XIRP2 antibodies exhibit varying species reactivity, with many commercial products showing confirmed reactivity against human and mouse XIRP2. The specificity of these antibodies has been verified through multiple approaches, including the absence of staining in XIRP2 knockout mice. As noted in one study, "XIRP2 was no longer enriched at gaps in Xirp2 knockout mice," confirming the specificity of the antibody staining pattern .
Some antibodies are designed to target specific isoforms of XIRP2. Research has identified at least two major isoforms: a long isoform primarily localized to the cuticular plate and cell junctions, and a short isoform enriched in stereocilia . Isoform-specific antibodies are valuable tools for distinguishing between these variants in experimental settings.
XIRP2 antibodies find utility in a diverse range of laboratory techniques, making them versatile tools for research on cellular structure, development, and disease mechanisms. The table below summarizes the main applications and recommended dilutions for XIRP2 antibody (Proteintech 11896-1-AP):
| Application | Recommended Dilution | Validated Samples |
|---|---|---|
| Western Blot (WB) | 1:500-1:1000 | COLO 320 cells, Caco-2 cells, human heart tissue |
| Immunohistochemistry (IHC) | 1:20-1:200 | Human skeletal muscle tissue, human heart tissue |
| Immunofluorescence (IF) | 1:50-1:500 | Mouse heart tissue |
| ELISA | Variable | Dependent on experimental design |
Table 1: Applications and recommended dilutions for XIRP2 antibody (Data from Proteintech)
XIRP2 antibodies have been successfully employed in western blot applications to detect the target protein in various cell types and tissue samples. When visualized on western blots, XIRP2 typically appears at a molecular weight of 260-300 kDa . For optimal results, researchers should follow specific protocols that account for the large size of the protein, including extended transfer times and appropriate gel concentrations.
XIRP2 antibodies are particularly valuable for visualizing the protein's localization in tissues through immunohistochemistry (IHC) and immunofluorescence (IF) techniques. These applications have revealed XIRP2 expression patterns during development and in various tissues, notably in skeletal and cardiac muscle, as well as in specialized structures like stereocilia in inner ear hair cells .
For IHC applications with the Proteintech antibody, antigen retrieval with TE buffer pH 9.0 is suggested, although citrate buffer pH 6.0 may also be used as an alternative . The immunofluorescence studies have provided particularly detailed insights into XIRP2 localization, with STED (Stimulated Emission Depletion) imaging showing "that XIRP2 is localized throughout the actin-rich stereocilia and cuticular plates of both cochlear and utricular hair cells" .
XIRP2 antibodies have been employed in developmental studies to track protein expression across different developmental stages. Gene expression assays using XIRP2 immunohistochemistry have examined expression patterns from embryonic day 15 through postnatal stages (P4, P10, P20, P30). These studies frequently employ double labeling techniques, with XIRP2 (labeled in green) and actin (labeled in red), allowing for co-localization analysis .
Understanding the structure and function of the target protein is essential for interpreting antibody-generated data correctly. XIRP2 is a large actin-binding protein with several notable structural and functional characteristics that influence its biological roles.
XIRP2 contains 28 Xin repeats, which are specialized domains that bind and stabilize actin bundles. This structural feature is central to the protein's function, as "Three Xin repeats can bind one actin molecule, so each XIRP2 long-isoform molecule, containing 28 Xin repeats, could bind multiple actin filaments" . This allows XIRP2 to cross-link actin filaments, particularly in stereocilia, potentially bundling them into parallel arrays similar to the function of the related protein XIRP1 .
XIRP2 exists in multiple isoforms, with up to 8 different isoforms reported in humans . Two major isoforms have been well-characterized:
Long isoform: The canonical form that lacks upstream exons -1 to -7, includes exon 7, and has a stop codon in exon 8 that prevents translation of exon 9. This isoform is primarily localized to the cuticular plate and cell junctions .
Short isoform: Includes exons -7, -6, and -1 (not present in the long form), lacks exons 1 and 7, and the reading frame of exon 8 permits translation through exon 9. This isoform is enriched in stereocilia .
XIRP2 shows notable expression in several tissues, including testis, skin, skeletal muscle, and heart muscle . Within the inner ear, XIRP2 expression increases markedly after embryonic day 16 (E16), suggesting an important role in the development and maintenance of actin-rich hair bundles .
XIRP2 plays crucial roles in maintaining cellular structure and function, particularly in tissues with high mechanical stress. Its primary function appears to be stabilizing actin filaments, which are essential components of the cytoskeleton. In inner ear hair cells, XIRP2 is essential for stereocilia maintenance and repair after noise-induced damage .
Recent research has revealed a novel mechanosensor domain in XIRP2 that facilitates the repair of noise-induced damage to stereocilia F-actin cores . This repair function is particularly important for maintaining auditory function, as "XIRP2 knockout mice have normal hair bundle development, but F-actin core disruption is visible as early as P7 and stereocilia degeneration is detectable by P12, leading to hearing loss by 7 weeks of age" .
XIRP2 antibodies have contributed significantly to understanding the protein's role in various pathological conditions, particularly in hearing disorders and cancer.
XIRP2 is crucial for maintaining stereocilia integrity in inner ear hair cells. Research using XIRP2 antibodies has demonstrated that the protein localizes to stereocilia F-actin gaps, where it facilitates repair after noise-induced damage . Studies in XIRP2 knockout mice have revealed that without this protein, gaps in stereocilia F-actin are not efficiently repaired after noise exposure, leading to progressive stereocilia degeneration and hearing loss .
The mechanism of XIRP2-mediated repair involves the recruitment of monomeric γ-actin to damaged sites. Immunostaining studies have shown that "γ-actin at these sites is likely to be primarily monomeric, as the phalloidin signal is weak, and DNaseI staining, which labels monomeric β- and γ-actin, is also enriched at phalloidin-negative gaps" . This recruitment of monomeric actin is necessary for repairing the F-actin cores of stereocilia, highlighting XIRP2's critical role in maintaining auditory function.
Recent research has identified XIRP2 mutations as significant factors in cancer development and progression. In hepatocellular carcinoma (HCC), XIRP2 mutation is one of the high-frequency mutations associated with poor prognosis and drug resistance . This finding suggests potential clinical applications for XIRP2 antibodies in cancer research and diagnostics.
Studies have shown that HCC cells carrying XIRP2 mutations exhibit altered drug sensitivity profiles compared to those with wild-type XIRP2. Specifically, cells with XIRP2 mutations demonstrate "increased resistance to fludarabine and oxaliplatin, but enhanced sensitivity to WEHI-539 and LCL-161" . These findings have important implications for personalized cancer therapy approaches.
Mechanistically, the XIRP2 mutation does not affect mRNA levels but enhances protein stability. Inhibition of XIRP2 "resulted in a significant increase in sensitivity to oxaliplatin through an elevation in zinc ions and a calcium ion overload" . This suggests that XIRP2 mutation status could serve as a biomarker for predicting drug sensitivity in HCC and potentially other cancer types.
XIRP2 (Xin Actin-Binding Repeat-Containing Protein 2) is an actin-binding protein highly enriched in inner ear hair cells. This protein contains 28 Xin repeats in its long isoform, which bind and stabilize actin bundles . XIRP2 is localized throughout the actin-rich stereocilia and cuticular plates of both cochlear and utricular hair cells, as confirmed by STED imaging . Its expression increases markedly after embryonic day 16 (E16), suggesting an important developmental role in actin-rich hair bundles .
Functionally, XIRP2 appears to be involved in the maintenance and repair of actin structures in stereocilia. It is particularly enriched at phalloidin-negative gaps in stereocilia, which represent sites of F-actin damage . XIRP2 remains enriched at repaired gaps, colocalized with newly synthesized β-actin following noise exposure . The protein may serve to cross-link actin filaments in stereocilia, as each XIRP2 long-isoform molecule could bind multiple actin filaments through its Xin repeats .
XIRP2 exists in multiple isoforms, with two primary variants identified in hair cells:
Long XIRP2 isoform: Contains the full 28 Xin repeats and is primarily localized to the cuticular plate and cell junctions in hair cells .
Short XIRP2 isoform (Genbank ID KM273012): Specifically and exclusively localizes to the hair bundle . Unlike the long isoform, the short XIRP2 isoform lacks the Xin repeats encoded by exon 7 but contains a LIM domain and a C-terminal domain (CTD) encoded by exons 8 and 9, respectively .
These isoforms can be distinguished using isoform-specific antibodies. Researchers have developed antibodies targeting:
The N-terminus common to both isoforms (pan-XIRP2 antibodies)
The alternative reading frame in exon 8 (specific to long XIRP2)
Immunofluorescence studies have shown that only short XIRP2 is enriched at gaps in phalloidin staining, highlighting the functional specialization of these isoforms .
XIRP2 antibodies have been successfully used in several experimental applications:
| Application | Recommended Dilution | Notes |
|---|---|---|
| Western Blot (WB) | 1/200 - 1/2000 | Observed molecular weight: ~280 kDa |
| Immunohistochemistry (IHC) | 1/20 - 1/200 | Effective for tissue sections |
| ELISA | Optimized per protocol | For quantitative detection |
| Immunofluorescence | 1/100 - 1/300 | Used for subcellular localization studies |
The optimal dilutions should be determined by the end user for each specific application and experimental system . When working with XIRP2 antibodies, researchers should consider the specificity for different isoforms, as demonstrated in the literature with pan-XIRP2 antibodies and isoform-specific antibodies .
XIRP2 antibodies provide a valuable tool for investigating noise-induced stereocilia damage and repair mechanisms. Research has shown that XIRP2 becomes enriched at sites of F-actin damage in stereocilia following noise exposure . This enrichment pattern can be exploited experimentally through the following methodology:
Experimental design: Expose mice to controlled noise conditions (typically 8–16 kHz at 100 dB SPL for 2 hours) and collect tissue samples at various timepoints post-exposure (1 hour, 8 hours, 1 week).
Double immunostaining approach: Use pan-XIRP2 antibodies in combination with β-actin or γ-actin antibodies to visualize both damage sites and repair processes.
Quantification method: Calculate the ratio of XIRP2 fluorescence intensity at the center of gaps compared to adjacent intact regions to assess XIRP2 enrichment (values >1.0 indicate enrichment) .
Temporal analysis: Track changes in XIRP2 enrichment and gap presence over time to assess repair progression. Research has shown that XIRP2-enriched sites in stereocilia cores do not significantly decrease 1 week following noise exposure, suggesting persistent repair activity .
This approach has revealed that XIRP2 appears to remain enriched at repaired gaps, colocalizing with newly synthesized β-actin after noise exposure, providing insights into the molecular mechanisms of stereocilia repair .
Validating XIRP2 antibody specificity is essential for generating reliable experimental data. Based on published research methodologies, the following validation approaches are recommended:
Knockout controls: Test antibodies in Xirp2 knockout mice tissues. Properly specific antibodies should show no enrichment at stereocilia gaps in these samples, as demonstrated in previous studies .
Isoform cross-reactivity assessment: When studying specific XIRP2 isoforms, test antibodies in CRISPR-modified mouse models (e.g., Xirp2ΔLIM/CTD mice) to confirm epitope-specific recognition .
Multiple antibodies approach: Use multiple antibodies targeting different epitopes of XIRP2 and compare staining patterns. Consistent localization with different antibodies increases confidence in specificity .
Heterologous expression systems: Express tagged XIRP2 constructs in cell lines (e.g., NIH-3T3) to validate antibody recognition via immunoprecipitation followed by Western blotting .
Peptide competition assays: Pre-incubate antibodies with the immunizing peptide to confirm that this blocks specific staining in tissues.
These validation steps are critical because many commercially available antibodies may show cross-reactivity or lack isoform specificity, potentially leading to misinterpretation of experimental results.
Based on published methodologies, the following protocol has been successfully used for XIRP2 detection in inner ear hair cells:
Fixation:
Fix dissected inner ear organs immediately in 4% paraformaldehyde for 20 minutes at room temperature .
Wash three times with phosphate-buffered saline (PBS) for 5 minutes each .
Blocking and Immunostaining:
Block for 2 hours with blocking buffer containing 1% bovine serum albumin (BSA), 3% normal donkey serum, and 0.2% saponin in PBS .
Incubate tissues in blocking buffer containing primary antibody at 4°C overnight .
Recommended dilutions:
Pan-XIRP2 antibodies: 1:100-1:200
Isoform-specific antibodies: 1:100
Incubate in blocking buffer containing appropriate secondary antibody at room temperature for 1.5 hours .
Mount on glass slides in ProLong Glass Antifade Mountant with a #1 coverslip .
This protocol preserves the delicate structure of stereocilia while allowing for specific detection of different XIRP2 isoforms. The inclusion of saponin in the blocking buffer is critical for membrane permeabilization without disrupting actin structures.
The interaction between XIRP2 and actin can be studied using several complementary approaches:
Co-immunoprecipitation assays: Transfect cells (e.g., NIH-3T3) with EGFP-tagged short XIRP2 and perform immunoprecipitation with GFP antibodies, followed by Western blotting for actin. This approach has demonstrated that both endogenous γ- and β-actin co-immunoprecipitate with XIRP2 .
Monomeric actin binding studies: Co-transfect cells with EGFP-tagged XIRP2 and HA-tagged γ-actin or polymerization-incompetent γ-actin mutants (G13R). Co-immunoprecipitation of both wild-type and mutant actin suggests XIRP2 can bind monomeric actin .
Domain mapping: Express truncated XIRP2 constructs (e.g., CTD-only) to identify specific domains responsible for actin binding. The C-terminal domain has been shown to be sufficient for binding monomeric actin .
In vivo functional studies: Compare actin dynamics in wild-type versus Xirp2 knockout or Xirp2ΔLIM/CTD mice. Decreased γ-actin enrichment at stereocilia gaps in mutant mice suggests XIRP2's role in recruiting actin monomers for repair .
These methodologies have revealed that XIRP2 interacts with both monomeric β- and γ-actin, and this interaction appears important for recruiting actin to sites of stereocilia damage .
Several key mouse models have been developed to study XIRP2 function in hair cells:
Complete Xirp2 knockout: These mice lack XIRP2 expression in all tissues and show no XIRP2 labeling in stereocilia or cuticular plates . This model allows for assessment of complete XIRP2 loss on hair cell development and function.
Xirp2ΔLIM/CTD mice: Generated using CRISPR/Cas9-mediated homology-directed repair, these mice express a truncated short XIRP2 isoform lacking the LIM domain and C-terminal domain . A 1-bp substitution in exon 8 (T1187A) introduces a stop codon before the beginning of the LIM domain in short XIRP2 (L396*) without altering the amino acid sequence of the long isoform .
Ptprq knockout mice: While not directly targeting XIRP2, these mice have been used as controls in XIRP2 studies, as PTPRQ plays a role in stereocilia development and maintenance .
The availability of these models, particularly the Xirp2ΔLIM/CTD mice, has enabled researchers to dissect the specific roles of XIRP2 domains in stereocilia maintenance and repair. For example, studies using these mice revealed that the LIM domain and CTD are necessary for XIRP2 enrichment at stereocilia gaps and subsequent recruitment of γ-actin .
The generation of domain-specific XIRP2 mutants using CRISPR-Cas9 requires careful design strategies, particularly when dealing with proteins with multiple isoforms that use alternative reading frames. Based on published methodologies, the following approach can be used:
Target site selection: Design single-guide RNAs (sgRNAs) targeting specific exons. For the Xirp2ΔLIM/CTD model, researchers targeted exon 8, which encodes the LIM domain of short XIRP2 .
Repair template design: Create a repair template with the desired mutation. For introducing a stop codon specifically in the short XIRP2 isoform, researchers used a 1-bp substitution (T1187A) that created a stop codon in the short isoform reading frame without affecting the long isoform's amino acid sequence .
RNP complex preparation: Precomplex Cas9 protein (50 ng/μl) with sgRNA (30 ng/μl) and co-inject with the repair template (50 ng/μl) into fertilized eggs .
Embryo implantation: Implant two-cell stage embryos into pseudopregnant female mice .
Founder screening: Perform PCR amplification of the region of interest followed by Sanger sequencing to identify founders with the desired mutation .
Backcrossing: Backcross founder mice for several generations (e.g., seven generations) to establish the mutant line on a pure genetic background .
This approach allows for precise modification of specific domains while minimizing off-target effects and maintaining expression of other isoforms, which is particularly valuable when studying multifunctional proteins like XIRP2.
To evaluate how XIRP2 mutations affect hearing function, researchers can employ a comprehensive approach combining physiological measurements with structural analyses:
Auditory Brainstem Response (ABR) testing: Measure hearing thresholds across different frequencies (typically 4-32 kHz) in wild-type versus mutant mice. This non-invasive technique assesses the electrical signals generated in response to sound stimuli, providing a functional readout of hearing sensitivity .
Distortion Product Otoacoustic Emissions (DPOAEs): Measure outer hair cell function specifically by recording the sounds generated by the cochlea in response to paired pure tone stimuli.
Vestibular-evoked potential (VsEP) measurements: For assessing vestibular function in addition to auditory function, particularly relevant since XIRP2 is expressed in both cochlear and vestibular hair cells .
Scanning Electron Microscopy (SEM): Examine stereocilia morphology at the ultrastructural level to detect abnormalities that might not be visible with light microscopy.
Phalloidin staining and gap quantification: Count the number of phalloidin-negative gaps in stereocilia before and after noise exposure to assess damage susceptibility and repair capacity .
Immunofluorescence analysis of repair proteins: Quantify the recruitment of repair proteins (e.g., γ-actin, β-actin, espin) to damage sites in wild-type versus mutant mice .
These methodologies have revealed that Xirp2ΔLIM/CTD mice show hearing deficits compared to wild-type mice, demonstrating the importance of the LIM domain and CTD for XIRP2's function in maintaining hearing .
Investigating XIRP2's role in stereocilia repair requires specialized techniques that can assess both structural and molecular changes following acoustic trauma:
Controlled noise exposure protocol: Subject mice to defined noise conditions (e.g., 8–16 kHz octave band noise at 100 dB SPL for 2 hours) and collect samples at specific timepoints (1 hour, 8 hours, 1 week post-exposure) .
β-actin incorporation assay: Use specialized mouse models expressing GFP-tagged β-actin under tamoxifen control to track newly synthesized actin at repair sites. This approach allows visualization of actin dynamics during the repair process .
Quantitative immunofluorescence: Measure the fluorescence intensity ratios of XIRP2 and actin isoforms at gap centers versus adjacent intact regions to assess protein recruitment during repair .
Time-course analysis: Compare phalloidin-negative gap numbers immediately after noise exposure versus recovery timepoints to assess repair efficiency in different genotypes .
Co-localization studies: Perform dual-labeling experiments with XIRP2 and repair proteins (actin isoforms, espin) to assess recruitment dependencies .
Super-resolution microscopy: Use techniques like STED (Stimulated Emission Depletion) microscopy to visualize nanoscale organization of repair proteins at damage sites .
These approaches have revealed that XIRP2 plays a crucial role in recruiting monomeric actin to damage sites, as evidenced by decreased β-actin and γ-actin enrichment at stereocilia gaps in Xirp2 knockout mice following noise exposure .